BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9577824)

  • 1. [The SCC antigen is not a reliable tumor marker in the ENT area. Value of squamous cell carcinoma antigen in diagnosis and follow-up of squamous epithelial carcinoma in the head-neck area. Results of a retrospective study over 6 years].
    Gotschuli A; Anderhuber W; Danninger R; Habermann W
    Laryngorhinootologie; 1998 Mar; 77(3):165-7. PubMed ID: 9577824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnosis of recurrences of head and neck carcinoma with the tumor marker SSC-antigen].
    Arlt A; Luckhaupt H; Hildmann H
    Laryngorhinootologie; 2000 Apr; 79(4):207-12. PubMed ID: 10838684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Relevance of the new tumor marker SCC (squamous cell carcinoma antigen) for the diagnosis and follow-up control of squamous epithelial carcinoma of the head and neck].
    Koch T; Eiffert H; Spindler MB
    HNO; 1989 Nov; 37(11):454-9. PubMed ID: 2584067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Squamous cell carcinoma antigen. Current clinical value of a new tumor marker in head and neck cancer; preliminary results of a prospective study after 12 months].
    Clasen B; Roettger D; Senekowitsch R; Menz E
    Laryngol Rhinol Otol (Stuttg); 1988 Aug; 67(8):420-5. PubMed ID: 3210877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck.
    Inal E; Laçin M; Asal K; Ceylan A; Köybaşioğlu A; Ileri F; Uslu SS
    Kulak Burun Bogaz Ihtis Derg; 2004; 12(1-2):23-30. PubMed ID: 16010093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Quantitative changes in the immunoglobulin G subclass system--a reliable tumor marker in squamous epithelial carcinoma in the area of the head-neck].
    Anderhuber W; Steinschifter W; Gotschuli A; Schauenstein E; Schauenstein K
    Laryngorhinootologie; 1998 Oct; 77(10):564-8. PubMed ID: 9842520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early predicting recurrent cervical cancer with combination of tissue polypeptide specific antigen (TPS) and squamous cell carcinoma antigen (SCC).
    Hung YC; Shiau YC; Chang WC; Kao CH; Lin CC
    Neoplasma; 2002; 49(6):415-7. PubMed ID: 12584591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Squamous cell carcinoma antigen in follow-up of cervical cancer treated with radiotherapy: evaluation of cost-effectiveness.
    Forni F; Ferrandina G; Deodato F; Macchia G; Morganti AG; Smaniotto D; Luzi S; D'Agostino G; Valentini V; Cellini N; Giardina B; Scambia G
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1145-9. PubMed ID: 17689030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokeratin subunit 19 measured by CYFRA 21-1 assay in follow-up of cervical cancer.
    Kainz C; Sliutz G; Mustafa G; Bieglmayr C; Koelbl H; Reinthaller A; Gitsch G
    Gynecol Oncol; 1995 Mar; 56(3):402-5. PubMed ID: 7535720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CYFRA 21-1 is not superior to SCC antigen and CEA in head and neck squamous cell cancer.
    Wollenberg B; Jan V; Schmit UM; Hofmann K; Stieber P; Fateh-Moghadam A
    Anticancer Res; 1996; 16(5B):3117-24. PubMed ID: 8920778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?
    Gaarenstroom KN; Kenter GG; Bonfrer JM; Korse CM; Van de Vijver MJ; Fleuren GJ; Trimbos JB
    Gynecol Oncol; 2000 Apr; 77(1):164-70. PubMed ID: 10739706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The diagnostic value of the tumor markers CEA, "Ca 19-9", "Ca 125", "Ca15-3" and "SCC" for the detection of recurrent tumors in patients with tumors of the head and neck].
    Zöller J; Fiehn W; Mende U; Hotz G
    Dtsch Z Mund Kiefer Gesichtschir; 1990; 14(4):254-9. PubMed ID: 2134649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SCC-RIA in the diagnosis of squamous cell carcinoma of the head and neck.
    Eibling DE; Johnson JT; Wagner RL; Su S
    Laryngoscope; 1989 Feb; 99(2):117-24. PubMed ID: 2913421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer.
    Tas F; Aydiner A; Topuz E; Yasasever V; Karadeniz A; Saip P
    J Exp Clin Cancer Res; 2000 Dec; 19(4):477-81. PubMed ID: 11277326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of combined use of macrophage colony-stimulating factor and squamous cell carcinoma antigen as a selective diagnostic marker for squamous cell carcinoma arising in mature cystic teratoma of the ovary.
    Suzuki M; Tamura N; Kobayashi H; Ohwada M; Terao T; Sato I
    Gynecol Oncol; 2000 Jun; 77(3):405-9. PubMed ID: 10831350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Squamous cell carcinoma antigen in oral squamous cell carcinomas.
    Nagumo K; Okada N; Takagi M; Yamamoto H; Amagasa T; Fujibayashi T
    Bull Tokyo Med Dent Univ; 1990 Jun; 37(1-2):27-34. PubMed ID: 2225283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [SCC (squamous cell carcinoma) antigen as a tumor marker in cervix cancers].
    Geyer H; Schwörer D; Pfleiderer A
    Geburtshilfe Frauenheilkd; 1989 Mar; 49(3):266-71. PubMed ID: 2721888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative serum squamous cell carcinoma antigen levels in clinical decision making for patients with early-stage cervical cancer.
    Reesink-Peters N; van der Velden J; Ten Hoor KA; Boezen HM; de Vries EG; Schilthuis MS; Mourits MJ; Nijman HW; Aalders JG; Hollema H; Pras E; Duk JM; van der Zee AG
    J Clin Oncol; 2005 Mar; 23(7):1455-62. PubMed ID: 15735121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyfra 21-1 as a serum tumor marker for follow-up of patients with laryngeal and hypopharyngeal squamous cell carcinoma.
    Al-Shagahin H; Alkotyfan K; Müller HH; Sesterhenn AM; Werner JA
    Anticancer Res; 2009 Aug; 29(8):3421-5. PubMed ID: 19661367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical value of serum squamous cell carcinoma antigen in the management of sinonasal inverted papilloma.
    Yasumatsu R; Nakashima T; Masuda M; Kuratomi Y; Shiratsuchi H; Hirakawa N; Tomita K; Yamamoto T; Komune S
    Head Neck; 2005 Jan; 27(1):44-8. PubMed ID: 15459916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.